Document is current
Any future updates will be listed below
-
Authors
Howes, Oliver http://orcid.org/0000-0002-2928-1972
Marcinkowska, Julia http://orcid.org/0009-0007-3120-1816
Turkheimer, Federico E. http://orcid.org/0000-0002-3766-3815
Carr, Richard
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_U120097115)
RCUK | Medical Research Council (MR/W005557/1)
RCUK | Medical Research Council (MR/V013734/1)
Wellcome Trust (094849/Z/10/Z)
- License Information
-
More Information
Article History
Received: 27 March 2024
Revised: 3 July 2024
Accepted: 19 July 2024
First Online: 12 August 2024
Competing interests
: OH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Elysium, Heptares, Global Medical Education, Invicro, Jansenn, Karuna, Lundbeck, Merck, Neurocrine, Ontrack/ Pangea, Otsuka, Sunovion, Recordati, Roche, Rovi and Viatris/Mylan. He was previously a part-time employee of Lundbeck A/v. OH has a patent for the use of dopaminergic imaging. RC, FET and JM have no competing interests to declare.
